Cargando…

A Perspective on Imiquimod Microneedles for Treating Warts

Warts are a common skin problem and are caused by infection with a virus. Warts are currently mainly treated by therapies involving ablating tissue or interrupting cellular division. However, all these existing treatments are either invasive or cause skin pain and tissue destruction. Imiquimod is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Tsu-Man, Hsu, Ping-Chun, Khan, Mohd Yaqub, Lin, Cheng-An J., Lee, Chun-Hung, Hsu, Tsai-Ching, Chen, Min-Hua, Hanagata, Nobutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146107/
https://www.ncbi.nlm.nih.gov/pubmed/33922157
http://dx.doi.org/10.3390/pharmaceutics13050607
_version_ 1783697323498405888
author Chiu, Tsu-Man
Hsu, Ping-Chun
Khan, Mohd Yaqub
Lin, Cheng-An J.
Lee, Chun-Hung
Hsu, Tsai-Ching
Chen, Min-Hua
Hanagata, Nobutaka
author_facet Chiu, Tsu-Man
Hsu, Ping-Chun
Khan, Mohd Yaqub
Lin, Cheng-An J.
Lee, Chun-Hung
Hsu, Tsai-Ching
Chen, Min-Hua
Hanagata, Nobutaka
author_sort Chiu, Tsu-Man
collection PubMed
description Warts are a common skin problem and are caused by infection with a virus. Warts are currently mainly treated by therapies involving ablating tissue or interrupting cellular division. However, all these existing treatments are either invasive or cause skin pain and tissue destruction. Imiquimod is a synthetic compound that belongs to the imidazoquinolinone family. It has been successfully used as a topical drug to treat external anogenital warts. However, topical imiquimod cream for warts is restricted by low skin permeability, and several side effects such as itching, pain, and erosions occur most frequently following topical treatment. Microneedle technology, a minimally invasive drug delivery system, has the potential to overcome the barrier of the stratum corneum. This technique would also offer a painless treatment choice and provide personalized therapies. In the study, we loaded imiquimod within dissolving microneedles using the molding method. Gelatin was used as a structural material for microneedle formation without adding a crosslinker. To our knowledge, this is the first study of using dissolving microneedles and exploring their utilization with imiquimod for the treatment of warts. First, we added fluorescent dye and trypan blue into the microneedles to evaluate the status of drugs in the microneedles and the degradation property of microneedles made of gelatin, respectively. Here we also prove the strength of the imiquimod microneedles and study their capability to penetrate the skin. The results show no apparent differences in mechanical failure after an additional imiquimod-loaded. Besides, we provide evidence that imiquimod microneedles induce secreted embryonic alkaline phosphatase (SEAP) in the RAW 264.7 macrophages. Gelatin does not affect the imiquimod in microneedles; a similar immune response was affected by the imiquimod alone or imiquimod complexed with gelatin. Our research demonstrates a proof of concept of using imiquimod microneedles for future warts treatment.
format Online
Article
Text
id pubmed-8146107
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81461072021-05-26 A Perspective on Imiquimod Microneedles for Treating Warts Chiu, Tsu-Man Hsu, Ping-Chun Khan, Mohd Yaqub Lin, Cheng-An J. Lee, Chun-Hung Hsu, Tsai-Ching Chen, Min-Hua Hanagata, Nobutaka Pharmaceutics Perspective Warts are a common skin problem and are caused by infection with a virus. Warts are currently mainly treated by therapies involving ablating tissue or interrupting cellular division. However, all these existing treatments are either invasive or cause skin pain and tissue destruction. Imiquimod is a synthetic compound that belongs to the imidazoquinolinone family. It has been successfully used as a topical drug to treat external anogenital warts. However, topical imiquimod cream for warts is restricted by low skin permeability, and several side effects such as itching, pain, and erosions occur most frequently following topical treatment. Microneedle technology, a minimally invasive drug delivery system, has the potential to overcome the barrier of the stratum corneum. This technique would also offer a painless treatment choice and provide personalized therapies. In the study, we loaded imiquimod within dissolving microneedles using the molding method. Gelatin was used as a structural material for microneedle formation without adding a crosslinker. To our knowledge, this is the first study of using dissolving microneedles and exploring their utilization with imiquimod for the treatment of warts. First, we added fluorescent dye and trypan blue into the microneedles to evaluate the status of drugs in the microneedles and the degradation property of microneedles made of gelatin, respectively. Here we also prove the strength of the imiquimod microneedles and study their capability to penetrate the skin. The results show no apparent differences in mechanical failure after an additional imiquimod-loaded. Besides, we provide evidence that imiquimod microneedles induce secreted embryonic alkaline phosphatase (SEAP) in the RAW 264.7 macrophages. Gelatin does not affect the imiquimod in microneedles; a similar immune response was affected by the imiquimod alone or imiquimod complexed with gelatin. Our research demonstrates a proof of concept of using imiquimod microneedles for future warts treatment. MDPI 2021-04-22 /pmc/articles/PMC8146107/ /pubmed/33922157 http://dx.doi.org/10.3390/pharmaceutics13050607 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Perspective
Chiu, Tsu-Man
Hsu, Ping-Chun
Khan, Mohd Yaqub
Lin, Cheng-An J.
Lee, Chun-Hung
Hsu, Tsai-Ching
Chen, Min-Hua
Hanagata, Nobutaka
A Perspective on Imiquimod Microneedles for Treating Warts
title A Perspective on Imiquimod Microneedles for Treating Warts
title_full A Perspective on Imiquimod Microneedles for Treating Warts
title_fullStr A Perspective on Imiquimod Microneedles for Treating Warts
title_full_unstemmed A Perspective on Imiquimod Microneedles for Treating Warts
title_short A Perspective on Imiquimod Microneedles for Treating Warts
title_sort perspective on imiquimod microneedles for treating warts
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146107/
https://www.ncbi.nlm.nih.gov/pubmed/33922157
http://dx.doi.org/10.3390/pharmaceutics13050607
work_keys_str_mv AT chiutsuman aperspectiveonimiquimodmicroneedlesfortreatingwarts
AT hsupingchun aperspectiveonimiquimodmicroneedlesfortreatingwarts
AT khanmohdyaqub aperspectiveonimiquimodmicroneedlesfortreatingwarts
AT linchenganj aperspectiveonimiquimodmicroneedlesfortreatingwarts
AT leechunhung aperspectiveonimiquimodmicroneedlesfortreatingwarts
AT hsutsaiching aperspectiveonimiquimodmicroneedlesfortreatingwarts
AT chenminhua aperspectiveonimiquimodmicroneedlesfortreatingwarts
AT hanagatanobutaka aperspectiveonimiquimodmicroneedlesfortreatingwarts
AT chiutsuman perspectiveonimiquimodmicroneedlesfortreatingwarts
AT hsupingchun perspectiveonimiquimodmicroneedlesfortreatingwarts
AT khanmohdyaqub perspectiveonimiquimodmicroneedlesfortreatingwarts
AT linchenganj perspectiveonimiquimodmicroneedlesfortreatingwarts
AT leechunhung perspectiveonimiquimodmicroneedlesfortreatingwarts
AT hsutsaiching perspectiveonimiquimodmicroneedlesfortreatingwarts
AT chenminhua perspectiveonimiquimodmicroneedlesfortreatingwarts
AT hanagatanobutaka perspectiveonimiquimodmicroneedlesfortreatingwarts